Liquid crystal display operating in a vertically aligned mode
AssigneeCrysoptix KK
InventorSerguei Petrovich Palto
Life of this patent
Estimating the term…
Abstract
The present invention relates generally to the field of liquid crystal display devices and more particularly to a liquid crystal display device operating in vertically aligned mode (VA-mode) in which liquid crystal molecules having a negative dielectric anisotropy are aligned generally perpendicularly to a panel surface of the liquid crystal display. A liquid crystal display according to the invention comprises a liquid crystal cell (6) of a vertical alignment mode, at least one polarizer (2, 10) arranged on each side of the liquid crystal cell, and at least one compensating structure (3, 7) disposed between the liquid crystal cell and at least one of the polarizers. The polarizers have transmission axes (11, 18) which are perpendicular to each other.
Claims32
A liquid crystal display comprising
- a vertical alignment mode liquid crystal cell,
- two polarizers arranged on each side of the liquid crystal cell, and
- at least one compensating structure located between the liquid crystal cell and one of said polarizers,
- wherein the polarizers have transmission axes which are perpendicular to each other, and
- the compensating structure comprises at least one retardation layer comprising
- supramolecules comprising at least one polycyclic organic compound with a conjugated π-system and functional groups which are capable of forming non-covalent bonds between said supramolecules,
- the organic compound having a general structural formula I
- where Sys is an at least partially conjugated substantially planar polycyclic molecular system,
- X is a carboxylic group —COOH,
- m is 0, 1, 2, 3 or 4;
- Y is a sulfonic group —SO3H,
- n is 0, 1, 2, 3 or 4;
- Z is a carboxamide,
- p is 0, 1, 2, 3 or 4;
- Q is a sulfonamide,
- v is 0, 1, 2, 3 or 4;
- D is a counterion;
- s is the number of counterions providing neutral state of the molecule;
- R is a substituent selected from the list comprising CH3, C2H5, Cl, Br, NO2, F, CF3, CN, OH, OCH3, OC2H5, OCOCH3, OCN, SCN, NH2, and NHCOCH3, and
- w is 0, 1, 2, 3 or 4,
- wherein Sys is substantially transparent in the visible spectral range having the general structural formula from the list comprising structures II to IV and VI to XLIX
- or wherein the organic compound is an acenaphthoquinoxaline derivative having a general structural formula corresponding to one of structures 13 to 25:
Dependencies are inferred from the claim text.